IL95800A - Biotin-labelled DNA by polymerase chain reaction and detection thereof - Google Patents

Biotin-labelled DNA by polymerase chain reaction and detection thereof

Info

Publication number: IL95800A
Authority: IL; Israel
Prior art keywords: primers; hybridization; nucleic acid; capture; capture probe
Prior art date: 1989-09-29

Application number

IL9580090A

Other languages

English (en)

Other versions

IL95800A0 (en

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-09-29

Filing date

1990-09-26

Publication date

1994-10-07

1990-09-26 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1991-06-30 Publication of IL95800A0 publication Critical patent/IL95800A0/xx

1994-10-07 Publication of IL95800A publication Critical patent/IL95800A/en

Links

238000001514 detection method Methods 0.000 title claims abstract description 40
238000003752 polymerase chain reaction Methods 0.000 title claims description 65
239000000523 sample Substances 0.000 claims abstract description 98
238000009396 hybridization Methods 0.000 claims abstract description 74
108091034117 Oligonucleotide Proteins 0.000 claims abstract description 60
108020004414 DNA Proteins 0.000 claims abstract description 51
238000003556 assay Methods 0.000 claims abstract description 43
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 36
229960002685 biotin Drugs 0.000 claims abstract description 20
239000011616 biotin Substances 0.000 claims abstract description 20
239000007787 solid Substances 0.000 claims abstract description 19
235000020958 biotin Nutrition 0.000 claims abstract description 18
241000606153 Chlamydia trachomatis Species 0.000 claims abstract description 16
230000003321 amplification Effects 0.000 claims abstract description 15
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 15
229940038705 chlamydia trachomatis Drugs 0.000 claims abstract description 13
238000002372 labelling Methods 0.000 claims abstract description 9
239000013615 primer Substances 0.000 claims description 79
238000000034 method Methods 0.000 claims description 55
150000007523 nucleic acids Chemical group 0.000 claims description 30
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 27
238000006243 chemical reaction Methods 0.000 claims description 23
238000012408 PCR amplification Methods 0.000 claims description 21
108020004707 nucleic acids Proteins 0.000 claims description 20
102000039446 nucleic acids Human genes 0.000 claims description 20
108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
239000004793 Polystyrene Substances 0.000 claims description 18
229920002223 polystyrene Polymers 0.000 claims description 18
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 16
230000000295 complement effect Effects 0.000 claims description 14
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical group NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 13
102000004190 Enzymes Human genes 0.000 claims description 13
108090000790 Enzymes Proteins 0.000 claims description 13
239000003153 chemical reaction reagent Substances 0.000 claims description 13
239000000758 substrate Substances 0.000 claims description 13
230000027455 binding Effects 0.000 claims description 10
108090001008 Avidin Proteins 0.000 claims description 9
239000003795 chemical substances by application Substances 0.000 claims description 9
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims description 8
108090000623 proteins and genes Proteins 0.000 claims description 8
102000004169 proteins and genes Human genes 0.000 claims description 8
108010006785 Taq Polymerase Proteins 0.000 claims description 7
238000010348 incorporation Methods 0.000 claims description 6
239000003446 ligand Substances 0.000 claims description 6
-1 deoxyr ibonucleotide triphosphates Chemical class 0.000 claims description 5
239000000463 material Substances 0.000 claims description 5
239000001226 triphosphate Substances 0.000 claims description 5
235000011178 triphosphate Nutrition 0.000 claims description 5
238000005406 washing Methods 0.000 claims description 5
239000003155 DNA primer Substances 0.000 claims description 4
150000001875 compounds Chemical class 0.000 claims description 4
239000005547 deoxyribonucleotide Substances 0.000 claims description 4
108040007629 peroxidase activity proteins Proteins 0.000 claims description 4
238000011002 quantification Methods 0.000 claims description 4
238000003345 scintillation counting Methods 0.000 claims description 3
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
108060001084 Luciferase Proteins 0.000 claims description 2
239000005089 Luciferase Substances 0.000 claims description 2
108010090804 Streptavidin Proteins 0.000 claims description 2
108010030694 avidin-horseradish peroxidase complex Proteins 0.000 claims description 2
102000005936 beta-Galactosidase Human genes 0.000 claims description 2
108010005774 beta-Galactosidase Proteins 0.000 claims description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 2
238000012986 modification Methods 0.000 claims description 2
230000004048 modification Effects 0.000 claims description 2
238000007899 nucleic acid hybridization Methods 0.000 claims description 2
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
238000009007 Diagnostic Kit Methods 0.000 claims 10
102000053602 DNA Human genes 0.000 claims 2
102000003992 Peroxidases Human genes 0.000 claims 2
239000012472 biological sample Substances 0.000 claims 2
238000000424 optical density measurement Methods 0.000 claims 2
108020004682 Single-Stranded DNA Proteins 0.000 claims 1
239000002738 chelating agent Substances 0.000 claims 1
229920001519 homopolymer Polymers 0.000 claims 1
229910052739 hydrogen Inorganic materials 0.000 claims 1
239000001257 hydrogen Substances 0.000 claims 1
125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
108091093088 Amplicon Proteins 0.000 abstract description 26
230000001419 dependent effect Effects 0.000 abstract description 2
239000000047 product Substances 0.000 description 43
239000013612 plasmid Substances 0.000 description 16
238000002105 Southern blotting Methods 0.000 description 14
238000010790 dilution Methods 0.000 description 13
239000012895 dilution Substances 0.000 description 13
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 12
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
239000013642 negative control Substances 0.000 description 12
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
238000011161 development Methods 0.000 description 11
229960001484 edetic acid Drugs 0.000 description 11
210000004027 cell Anatomy 0.000 description 10
239000000499 gel Substances 0.000 description 10
238000002360 preparation method Methods 0.000 description 10
239000002987 primer (paints) Substances 0.000 description 10
239000000243 solution Substances 0.000 description 9
238000000137 annealing Methods 0.000 description 8
238000004925 denaturation Methods 0.000 description 8
230000036425 denaturation Effects 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
108010001336 Horseradish Peroxidase Proteins 0.000 description 7
239000013504 Triton X-100 Substances 0.000 description 7
229920004890 Triton X-100 Polymers 0.000 description 7
239000011541 reaction mixture Substances 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 5
239000005695 Ammonium acetate Substances 0.000 description 5
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 5
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 5
229940043376 ammonium acetate Drugs 0.000 description 5
235000019257 ammonium acetate Nutrition 0.000 description 5
238000002820 assay format Methods 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
108091033319 polynucleotide Proteins 0.000 description 5
239000002157 polynucleotide Substances 0.000 description 5
102000040430 polynucleotide Human genes 0.000 description 5
108091003079 Bovine Serum Albumin Proteins 0.000 description 4
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
238000000211 autoradiogram Methods 0.000 description 4
229940098773 bovine serum albumin Drugs 0.000 description 4
230000000120 cytopathologic effect Effects 0.000 description 4
239000012528 membrane Substances 0.000 description 4
239000000203 mixture Substances 0.000 description 4
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
108010017826 DNA Polymerase I Proteins 0.000 description 3
102000004594 DNA Polymerase I Human genes 0.000 description 3
239000003298 DNA probe Substances 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
241000725303 Human immunodeficiency virus Species 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
238000000376 autoradiography Methods 0.000 description 3
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 3
239000000872 buffer Substances 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
239000005457 ice water Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
230000001939 inductive effect Effects 0.000 description 3
239000012160 loading buffer Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
229920002401 polyacrylamide Polymers 0.000 description 3
238000000746 purification Methods 0.000 description 3
239000011535 reaction buffer Substances 0.000 description 3
238000011160 research Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 3
OXEUETBFKVCRNP-UHFFFAOYSA-N 9-ethyl-3-carbazolamine Chemical compound NC1=CC=C2N(CC)C3=CC=CC=C3C2=C1 OXEUETBFKVCRNP-UHFFFAOYSA-N 0.000 description 2
241000606161 Chlamydia Species 0.000 description 2
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
241000711549 Hepacivirus C Species 0.000 description 2
241000701806 Human papillomavirus Species 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
108020004518 RNA Probes Proteins 0.000 description 2
239000003391 RNA probe Substances 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
241000700605 Viruses Species 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000006287 biotinylation Effects 0.000 description 2
238000007413 biotinylation Methods 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
238000001816 cooling Methods 0.000 description 2
125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 2
229960004963 mesalazine Drugs 0.000 description 2
ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
102000013415 peroxidase activity proteins Human genes 0.000 description 2
235000020030 perry Nutrition 0.000 description 2
239000013641 positive control Substances 0.000 description 2
238000011158 quantitative evaluation Methods 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
UVGHPGOONBRLCX-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoate Chemical compound S1CC2NC(=O)NC2C1CCCCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O UVGHPGOONBRLCX-UHFFFAOYSA-N 0.000 description 1
WZIMSXIXZTUBSO-UHFFFAOYSA-N 2-[[bis(carboxymethyl)amino]methyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CN(CC(O)=O)CC(O)=O WZIMSXIXZTUBSO-UHFFFAOYSA-N 0.000 description 1
SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
PCDWFBFHIIKIPM-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-2-sulfonic acid Chemical compound C1=CC=C2N(CC)C(S(O)(=O)=O)SC2=C1 PCDWFBFHIIKIPM-UHFFFAOYSA-N 0.000 description 1
YUDPTGPSBJVHCN-DZQJYWQESA-N 4-methylumbelliferyl beta-D-galactoside Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YUDPTGPSBJVHCN-DZQJYWQESA-N 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
229920002799 BoPET Polymers 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000702224 Enterobacteria phage M13 Species 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
239000005041 Mylar™ Substances 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
239000012807 PCR reagent Substances 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
101710136739 Teichoic acid poly(glycerol phosphate) polymerase Proteins 0.000 description 1
241000589500 Thermus aquaticus Species 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
239000011324 bead Substances 0.000 description 1
150000001615 biotins Chemical class 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
229960000633 dextran sulfate Drugs 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000003505 heat denaturation Methods 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
125000001245 hexylamino group Chemical group [H]N([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000005291 magnetic effect Effects 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
108700026241 pX Genes Proteins 0.000 description 1
244000045947 parasite Species 0.000 description 1
239000002245 particle Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
125000006853 reporter group Chemical group 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
101150027303 tax gene Proteins 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000011282 treatment Methods 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000003643 water by type Substances 0.000 description 1
NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Chemical Kinetics & Catalysis (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Dental Preparations (AREA)
Transplanting Machines (AREA)

IL9580090A 1989-09-29 1990-09-26 Biotin-labelled DNA by polymerase chain reaction and detection thereof IL95800A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/414,542 US5232829A (en)	1989-09-29	1989-09-29	Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes

Publications (2)

Publication Number	Publication Date
IL95800A0 IL95800A0 (en)	1991-06-30
IL95800A true IL95800A (en)	1994-10-07

Family

ID=23641905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9580090A IL95800A (en)	1989-09-29	1990-09-26	Biotin-labelled DNA by polymerase chain reaction and detection thereof

Country Status (14)

Country	Link
US (1)	US5232829A (fr)
EP (2)	EP0875583B1 (fr)
JP (1)	JP2719225B2 (fr)
AT (2)	ATE345398T1 (fr)
AU (2)	AU6329090A (fr)
BR (1)	BR9004881A (fr)
CA (1)	CA2026280C (fr)
DE (2)	DE69034232T2 (fr)
DK (2)	DK0420260T3 (fr)
ES (2)	ES2275292T3 (fr)
IL (1)	IL95800A (fr)
NO (1)	NO302204B1 (fr)
NZ (2)	NZ235463A (fr)
ZA (1)	ZA907706B (fr)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5753433A (en) *	1909-12-05	1998-05-19	Boehringer Mannheim Gmbh	Method for the sensitive detection of nucleic acids
DE4038804A1 (de) *	1990-10-09	1992-04-16	Boehringer Mannheim Gmbh	Verfahren zur genus- oder/und spezies-spezifischen detektion von bakterien in einer probenfluessigkeit
US5750338A (en) *	1986-10-23	1998-05-12	Amoco Corporation	Target and background capture methods with amplification for affinity assays
US5714380A (en) *	1986-10-23	1998-02-03	Amoco Corporation	Closed vessel for isolating target molecules and for performing amplification
US6406844B1 (en)	1989-06-07	2002-06-18	Affymetrix, Inc.	Very large scale immobilized polymer synthesis
US6309822B1 (en)	1989-06-07	2001-10-30	Affymetrix, Inc.	Method for comparing copy number of nucleic acid sequences
US6551784B2 (en)	1989-06-07	2003-04-22	Affymetrix Inc	Method of comparing nucleic acid sequences
US5547839A (en)	1989-06-07	1996-08-20	Affymax Technologies N.V.	Sequencing of surface immobilized polymers utilizing microflourescence detection
US5744101A (en)	1989-06-07	1998-04-28	Affymax Technologies N.V.	Photolabile nucleoside protecting groups
US6919211B1 (en)	1989-06-07	2005-07-19	Affymetrix, Inc.	Polypeptide arrays
US5800992A (en)	1989-06-07	1998-09-01	Fodor; Stephen P.A.	Method of detecting nucleic acids
US6955915B2 (en)	1989-06-07	2005-10-18	Affymetrix, Inc.	Apparatus comprising polymers
US6416952B1 (en)	1989-06-07	2002-07-09	Affymetrix, Inc.	Photolithographic and other means for manufacturing arrays
US6346413B1 (en)	1989-06-07	2002-02-12	Affymetrix, Inc.	Polymer arrays
US5424186A (en)	1989-06-07	1995-06-13	Affymax Technologies N.V.	Very large scale immobilized polymer synthesis
US5143854A (en)	1989-06-07	1992-09-01	Affymax Technologies N.V.	Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6040138A (en)	1995-09-15	2000-03-21	Affymetrix, Inc.	Expression monitoring by hybridization to high density oligonucleotide arrays
US5232829A (en) *	1989-09-29	1993-08-03	Hoffmann-La Roche Inc.	Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
US6506558B1 (en)	1990-03-07	2003-01-14	Affymetrix Inc.	Very large scale immobilized polymer synthesis
IT1248685B (it) *	1990-06-04	1995-01-26	Tecnogen Scpa	Procedimento per la identificazione di sequenze polinucleotidiche e dispositivo relativo
US5695926A (en) *	1990-06-11	1997-12-09	Bio Merieux	Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
FR2663040B1 (fr) *	1990-06-11	1995-09-15	Bio Merieux	Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich.
JPH0499500A (ja) *	1990-08-17	1992-03-31	Kikkoman Corp	アビジンまたはアビジン標識体の定量法およびビオチンまたはビオチン標識体の定量法
US5635348A (en) *	1990-10-05	1997-06-03	Hoffmann-La Roche Inc.	Method and probes for identifying bacteria found in blood
NZ240079A (en) *	1990-10-09	1993-07-27	Boehringer Mannheim Gmbh	Method for the detection of a nucleic acid or part thereof
JPH06502766A (ja) *	1990-11-14	1994-03-31	アクゾ・ノベル・ナムローゼ・フェンノートシャップ	ポリスチレン支持体ベース−サンドイッチハイブリダイゼーションアッセイ法を用いる核酸の非同位体検出およびそれに用いる組成物
EP0834575B1 (fr)	1990-12-06	2001-11-28	Affymetrix, Inc. (a Delaware Corporation)	Identification d'acides nucléiques dans des échantillons
FR2679255B1 (fr) *	1991-07-17	1993-10-22	Bio Merieux	Procede d'immobilisation d'un fragment nucleique par fixation passive sur un support solide, support solide ainsi obtenu et son utilisation.
BR9206705A (pt) *	1991-11-01	1995-11-21	Adelaide Children S Hospital	Processo de amplificação de fase sólida
CA2124087C (fr) *	1991-11-22	2002-10-01	James L. Winkler	Techniques combinees pour la synthese de polymeres
US6943034B1 (en)	1991-11-22	2005-09-13	Affymetrix, Inc.	Combinatorial strategies for polymer synthesis
US6468740B1 (en)	1992-11-05	2002-10-22	Affymetrix, Inc.	Cyclic and substituted immobilized molecular synthesis
US6849462B1 (en)	1991-11-22	2005-02-01	Affymetrix, Inc.	Combinatorial strategies for polymer synthesis
AU2844792A (en) *	1991-12-11	1993-06-17	Becton Dickinson & Company	Probes to chlamydia trachomatis
EP0726963A4 (fr) *	1991-12-23	1998-05-13	Chiron Corp	SONDES POUR -i(CHLAMYDIAE) UTILISEES DANS DES METHODES D'HYBRIDATION EN SANDWICH EN PHASE DE SOLUTION
WO1993015228A1 (fr) *	1992-01-29	1993-08-05	Hitachi Chemical Co., Ltd.	Support d'immobilisation de polynucleotide
WO1993020234A1 (fr) *	1992-03-31	1993-10-14	E.I. Du Pont De Nemours And Company	Dosage rapide, a haute capacite, fonde sur l'acide nucleique
DE4212555A1 (de) *	1992-04-15	1993-10-21	Boehringer Mannheim Gmbh	Verfahren zum Nachweis von Nukleinsäuren
US5849544A (en) *	1992-07-24	1998-12-15	University Of Australia	Amplification and detection process
DE69327454T2 (de) *	1992-10-09	2000-05-11	Vysis, Inc.	Analytisches verfahren
US5545528A (en) *	1993-04-15	1996-08-13	Hitachi Chemical Research Center	Rapid screening method of gene amplification products in polypropylene plates
WO1994026934A2 (fr) *	1993-05-06	1994-11-24	Baxter Diagnostics Inc.	Methode de detection du papillomavirus chez l'homme
US5550040A (en) *	1993-06-23	1996-08-27	Hoffman-La Roche Inc.	Method, reagents and kits for the detection of Neisseria gonorrhoeae
US5601978A (en) *	1993-09-03	1997-02-11	Abbott Laboratories	Oligonucleotides and methods for the detection of chlamydia trachomatis
AU7718594A (en) *	1993-09-03	1995-03-22	United States Of America As Represented By The Secretary Department Of Health And Human Services	Method and compositions for primer specific solid-phase detection of pcr products
FR2716263B1 (fr) *	1994-02-11	1997-01-17	Pasteur Institut	Procédé d'alignement de macromolécules par passage d'un ménisque et applications dans un procédé de mise en évidence, séparation et/ou dosage d'une macromolécule dans un échantillon.
US6037127A (en) *	1994-03-31	2000-03-14	E. I. Du Pont De Nemours And Company	Method for detection of non-denatured nucleic acid fragments
US5480783A (en) *	1994-03-31	1996-01-02	The Perkin-Elmer Corporation	Method for reducing background signals in DNA replication/detection assays
US5547861A (en) *	1994-04-18	1996-08-20	Becton, Dickinson And Company	Detection of nucleic acid amplification
US7323298B1 (en)	1994-06-17	2008-01-29	The Board Of Trustees Of The Leland Stanford Junior University	Microarray for determining the relative abundances of polynuceotide sequences
US7378236B1 (en)	1994-06-17	2008-05-27	The Board Of Trustees Of The Leland Stanford Junior University	Method for analyzing gene expression patterns
US20030026782A1 (en) *	1995-02-07	2003-02-06	Arthur M. Krieg	Immunomodulatory oligonucleotides
EP0705905B1 (fr) *	1994-07-16	2001-10-10	Roche Diagnostics GmbH	Procédé pour la détection sensible d'acides nucléiques
US5514551A (en) *	1994-10-14	1996-05-07	Gen-Probe Incorporated	Compositions for the detection of Chlamydia trachomatis
US8236493B2 (en)	1994-10-21	2012-08-07	Affymetrix, Inc.	Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
CA2163393C (fr) *	1994-11-30	2003-04-22	Colleen Marie Nycz	Amplification et detection d'acides nucleiques mycobacteriens
US6022689A (en) *	1995-04-07	2000-02-08	University Of New Mexico	Situ hybridization slide processes
US5989813A (en) *	1995-07-13	1999-11-23	Molecular Innovations, Inc.	Detection of amplified nucleic acid sequences using bifunctional haptenization and dyed microparticles
US6027879A (en) *	1995-08-09	2000-02-22	The Regents Of The University Of California	Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
US5800989A (en) *	1995-11-15	1998-09-01	Becton, Dickinson And Company	Method for detection of nucleic acid targets by amplification and fluorescence polarization
EP0880598A4 (fr) *	1996-01-23	2005-02-23	Affymetrix Inc	Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
US5814490A (en) *	1996-06-11	1998-09-29	Becton, Dickinson And Company	Amplification and detection of chlamydia trachomatis nucleic acids
AU4151697A (en) *	1996-08-14	1998-03-06	Vanderbilt University	Compositions of antichlamydial agents for the diagnosis and management of infection caused by (chlamydia)
WO1998013527A2 (fr) *	1996-09-24	1998-04-02	Rapigene, Inc.	Compositions et procedes pour l'augmentation de la specificite d'hybridation
US6361940B1 (en)	1996-09-24	2002-03-26	Qiagen Genomics, Inc.	Compositions and methods for enhancing hybridization and priming specificity
EP0952228A3 (fr) *	1996-09-24	1999-12-15	Rapigene, Inc.	Compositions et méthodes pour améliorer la spécificité des hybridations
US6143496A (en)	1997-04-17	2000-11-07	Cytonix Corporation	Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US6391655B1 (en) *	1997-07-30	2002-05-21	Corning Incorporated	Oxidized styrenic polymers for DNA binding
US6096501A (en) *	1997-11-04	2000-08-01	Becton Dickinson And Company	Assay for Chlamydia trachomatis by amplification and detection of Chlamydia trachomatis crytpic plasmid
DE19811732A1 (de) *	1998-03-18	1999-09-30	November Ag Molekulare Medizin	Mikrotiterplatte und Verfahren zum Nachweis von Biomolekülen
US6261769B1 (en)	1998-03-31	2001-07-17	The United States Of America As Represented By The Secretary Of Agriculture	Intergenic spacer target sequence for detecting and distinguishing Chlamydial species or strains
DE19824900B4 (de) *	1998-06-04	2006-05-04	Roche Diagnostics Gmbh	DNA-Nachweis über einen Strangreassoziationskomplex
US6545264B1 (en)	1998-10-30	2003-04-08	Affymetrix, Inc.	Systems and methods for high performance scanning
DE19916929A1 (de)	1999-04-15	2000-10-19	Bayer Ag	Ein automatisierbarer Schnelltest zum Nachweis von Krebserkrankungen auf der Basis von Telomerase(hTC) mRNA mit spezifischen Primern und Sonden
US6248537B1 (en)	1999-05-28	2001-06-19	Institut Pasteur	Use of the combing process for the identification of DNA origins of replication
FR2803913B1 (fr)	2000-01-13	2002-08-16	Pasteur Sanofi Diagnostics	Procede d'immobilisation de reactif(s) affin(s) sur phase solide hydrophobe
US8076063B2 (en)	2000-02-07	2011-12-13	Illumina, Inc.	Multiplexed methylation detection methods
US7955794B2 (en)	2000-09-21	2011-06-07	Illumina, Inc.	Multiplex nucleic acid reactions
US7582420B2 (en)	2001-07-12	2009-09-01	Illumina, Inc.	Multiplex nucleic acid reactions
US7611869B2 (en)	2000-02-07	2009-11-03	Illumina, Inc.	Multiplexed methylation detection methods
DK1259643T3 (da) *	2000-02-07	2009-02-23	Illumina Inc	Fremgangsmåde til detektion af nukleinsyre ved anvendelse af universel priming
EP1164201A1 (fr) *	2000-06-14	2001-12-19	Facultés Universitaires Notre-Dame de la Paix	Détection inverse pour l'identification et/ou quantification des nucléotides cibles par des biopuces
GB0016836D0 (en)	2000-07-07	2000-08-30	Lee Helen	Improved dipstick assays (1)
US6682889B1 (en)	2000-11-08	2004-01-27	Becton, Dickinson And Company	Amplification and detection of organisms of the Chlamydiaceae family
JP2002176985A (ja) *	2000-12-14	2002-06-25	Hitachi Software Eng Co Ltd	Ｐｃｒ増幅された塩基配列の検出方法及び検出キット
US20030104354A1 (en) *	2001-11-30	2003-06-05	Reliance Life Sciences Private Limited	Method and device for the rapid clinical diagnosis of human cytomegalovirus (hCMV) infection in biological samples
CA2467814A1 (fr) *	2001-12-03	2003-06-12	Illumina, Inc.	Procedes multiplexes de detection de methylation
KR100532664B1 (ko) *	2002-09-09	2005-12-02	주식회사 바이오메드랩	클라미디아 트라코마티스 탐지용 프로브, 이를 포함하는 클라미디아 트라코마티스 탐지용 키트, 및 이를 이용한 클라미디아 트라코마티스의 탐지방법
US7807802B2 (en)	2002-11-12	2010-10-05	Abbott Lab	Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
JP2004261017A (ja) *	2003-02-27	2004-09-24	Arkray Inc	クラミジア・トラコマティスの検出方法およびそのためのキット
EP1611254B1 (fr)	2003-03-31	2014-09-10	Roche Diagnostics GmbH	Compositions et procedes permettant de detecter certains flavivirus, notamment des membres du serogroupe du virus de l'encephalite japonaise
WO2004094986A2 (fr) *	2003-04-16	2004-11-04	Handylab, Inc.	Systeme et procede de detection electrochimique de composes biologiques
US7939251B2 (en)	2004-05-06	2011-05-10	Roche Molecular Systems, Inc.	SENP1 as a marker for cancer
US7338763B2 (en)	2004-06-02	2008-03-04	Eppendorf Array Technologies S.A.	Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays
US20060134650A1 (en) *	2004-12-21	2006-06-22	Illumina, Inc.	Methylation-sensitive restriction enzyme endonuclease method of whole genome methylation analysis
WO2007115059A2 (fr)	2006-03-29	2007-10-11	Merial Limited	Vaccin anti-streptocoques
WO2009029648A2 (fr)	2007-08-27	2009-03-05	Applera Corporation	Procédés et compositions pour une pcr
US20100323365A1 (en) *	2008-02-08	2010-12-23	Tomokazu Ishikawa	Primer and probe for detecting chlamydophila caviae, as well as a chlamydophila caviae detection method using the same
WO2010080691A1 (fr) *	2009-01-06	2010-07-15	Qimin You	Amplification d'acides nucléiques cibles par amorçage croisé
WO2011118496A1 (fr)	2010-03-23	2011-09-29	和光純薬工業株式会社	Amorce et sonde conçues pour détecter chlamydia trachomatis et procédé de détection de chlamydia trachomatis les utilisant
AT512416B1 (de)	2012-02-13	2013-10-15	Greiner Bio One Gmbh	Anordnung und verfahren zum nachweis von mikroorganismen in einem kulturgefäss
EA028686B1 (ru) *	2014-11-14	2017-12-29	Общество с ограниченной ответственностью "ИнтерЛабСервис"	Набор реагентов для выявления днк chlamydia trachomatis и его применение
CA3029682A1 (fr) *	2016-06-30	2018-01-04	Click Diagnostics, Inc.	Dispositifs et methodes d'extraction d'acides nucleiques
WO2018208726A1 (fr) *	2017-05-08	2018-11-15	Rensselaer Polytechnic Institute	Détection multiplex d'agents pathogènes bactériens par l'intermédiaire de complexes de domaine de liaison à la paroi cellulaire
US10323272B1 (en) *	2018-01-31	2019-06-18	Enzo Biochem, Inc.	Nucleic acid probes for in situ hybridization
US10450616B1 (en) *	2018-05-09	2019-10-22	Talis Biomedical Corporation	Polynucleotides for the amplification and detection of Chlamydia trachomatis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4154795A (en) *	1976-07-23	1979-05-15	Dynatech Holdings Limited	Microtest plates
US4228237A (en) *	1978-09-21	1980-10-14	Calbiochem-Behring Corp.	Methods for the detection and determination of ligands
US4358535A (en) *	1980-12-08	1982-11-09	Board Of Regents Of The University Of Washington	Specific DNA probes in diagnostic microbiology
FI63596C (fi) *	1981-10-16	1983-07-11	Orion Yhtymae Oy	Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser
US4725388A (en) *	1982-10-12	1988-02-16	Dynatech Laboratories, Inc.	Non-fluorescent vessels for holding test samples in fluorescent assays
GB8311905D0 (en) *	1983-04-29	1983-06-02	Cox R A	Isolation and detection of nucleotide sequence
FI71768C (fi) *	1984-02-17	1987-02-09	Orion Yhtymae Oy	Foerbaettrade nykleinsyrareagenser och foerfarande foer deras framstaellning.
GB8507706D0 (en) *	1985-03-25	1985-05-01	Genetics Int Inc	Magnetic nucleic acid sequences
US4683202A (en) *	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4683195A (en) *	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4751177A (en) *	1985-06-13	1988-06-14	Amgen	Methods and kits for performing nucleic acid hybridization assays
US4797355A (en) *	1985-06-13	1989-01-10	Amgen Inc.	Methods for attaching polynucleotides to supports
US4822731A (en) *	1986-01-09	1989-04-18	Cetus Corporation	Process for labeling single-stranded nucleic acids and hybridizaiton probes
FI76119C (fi) *	1986-02-27	1988-09-09	Orion Yhtymae Oy	Kvantitativ bestaemning av nukleinsyramolekyler och reagensfoerpackning som anvaends vid foerfarandet.
CA1284931C (fr) *	1986-03-13	1991-06-18	Henry A. Erlich	Procede de detection de variations specifiques de nucleotides et de polymorphismes genetiques dans les acides nucleiques
CA1301606C (fr) *	1986-05-02	1992-05-26	David H. Gillespie	Methode chaotropique pour l'evaluation d'acides nucleiques dans un echantillon biologique
WO1988003957A1 (fr) *	1986-11-24	1988-06-02	Gen-Probe Incorporated	Sondes d'acide nucleique pour la detection et/ou la quantification d'organismes non viraux
FR2607518B1 (fr) *	1986-12-01	1989-10-20	Transgene Sa	Vecteur viral et adn recombinant codant pour la proteine p25 du virus agent causal du s.i.d.a., culture cellulaire infectee, proteine obtenue, vaccin et anticorps obtenus
AU622104B2 (en) *	1987-03-11	1992-04-02	Sangtec Molecular Diagnostics Ab	Method of assaying of nucleic acids, a reagent combination and kit therefore
JPH07107537B2 (ja) *	1987-08-03	1995-11-15	イーストマンコダックカンパニー	アビジン−及びビオチン−固定試薬，分析要素並びにその使用法
CA1339351C (fr) *	1987-10-15	1997-08-26	Michael S. Urdea	Multimeres d'acide nucleique et essais d'hybridation amplifiee d'acide nucleique
IT1224253B (it) *	1988-04-08	1990-09-26	Sclavo Spa	Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico
JP2897959B2 (ja) *	1988-05-20	1999-05-31	エフ．ホフマン―ラロシュアクチェンゲゼルシャフト	固定化された配列特異的プローブ
KR920700360A (ko) *	1989-03-22	1992-02-19	하리크 프리드리히	미끄럼 베어링
US5232829A (en) *	1989-09-29	1993-08-03	Hoffmann-La Roche Inc.	Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
CA2031659A1 (fr) *	1990-01-26	1991-07-27	John B. Findlay	Reactif hydrosoluble; sonde d'acide nucleique; trousse d'essai et diagnostic; methodes de purification

1989
- 1989-09-29 US US07/414,542 patent/US5232829A/en not_active Expired - Lifetime
1990
- 1990-09-26 NZ NZ235463A patent/NZ235463A/en unknown
- 1990-09-26 IL IL9580090A patent/IL95800A/en not_active IP Right Cessation
- 1990-09-26 NZ NZ247522A patent/NZ247522A/en unknown
- 1990-09-26 CA CA002026280A patent/CA2026280C/fr not_active Expired - Lifetime
- 1990-09-26 ZA ZA907706A patent/ZA907706B/xx unknown
- 1990-09-27 EP EP98111076A patent/EP0875583B1/fr not_active Expired - Lifetime
- 1990-09-27 DK DK90118620T patent/DK0420260T3/da active
- 1990-09-27 DE DE69034232T patent/DE69034232T2/de not_active Expired - Lifetime
- 1990-09-27 AU AU63290/90A patent/AU6329090A/en not_active Abandoned
- 1990-09-27 DE DE69033387T patent/DE69033387T2/de not_active Expired - Lifetime
- 1990-09-27 AT AT98111076T patent/ATE345398T1/de not_active IP Right Cessation
- 1990-09-27 ES ES98111076T patent/ES2275292T3/es not_active Expired - Lifetime
- 1990-09-27 DK DK98111076T patent/DK0875583T3/da active
- 1990-09-27 AT AT90118620T patent/ATE187499T1/de not_active IP Right Cessation
- 1990-09-27 ES ES90118620T patent/ES2140372T3/es not_active Expired - Lifetime
- 1990-09-27 EP EP90118620A patent/EP0420260B1/fr not_active Expired - Lifetime
- 1990-09-28 NO NO904240A patent/NO302204B1/no not_active IP Right Cessation
- 1990-09-28 BR BR909004881A patent/BR9004881A/pt not_active Application Discontinuation
- 1990-09-29 JP JP2262934A patent/JP2719225B2/ja not_active Expired - Lifetime
1994
- 1994-09-02 AU AU72804/94A patent/AU685144B2/en not_active Expired

Also Published As

Publication number	Publication date
IL95800A0 (en)	1991-06-30
EP0420260A2 (fr)	1991-04-03
AU7280494A (en)	1994-11-24
JPH03206898A (ja)	1991-09-10
ES2275292T3 (es)	2007-06-01
EP0420260B1 (fr)	1999-12-08
CA2026280A1 (fr)	1991-03-30
NO302204B1 (no)	1998-02-02
EP0875583A2 (fr)	1998-11-04
EP0875583B1 (fr)	2006-11-15
CA2026280C (fr)	2003-04-15
DK0875583T3 (da)	2007-02-26
JP2719225B2 (ja)	1998-02-25
DE69034232D1 (de)	2006-12-28
ATE187499T1 (de)	1999-12-15
ES2140372T3 (es)	2000-03-01
AU6329090A (en)	1991-04-11
NO904240D0 (no)	1990-09-28
NZ247522A (en)	1994-03-25
NZ235463A (en)	1994-03-25
NO904240L (no)	1991-04-02
AU685144B2 (en)	1998-01-15
DE69033387T2 (de)	2000-03-30
US5232829A (en)	1993-08-03
DE69034232T2 (de)	2007-03-01
EP0420260A3 (en)	1991-09-18
BR9004881A (pt)	1991-09-10
DE69033387D1 (de)	2000-01-13
EP0875583A3 (fr)	1999-02-17
ATE345398T1 (de)	2006-12-15
ZA907706B (en)	1991-06-26
DK0420260T3 (da)	2000-03-27

Legal Events

Date	Code	Title
1996-11-14	KB	Patent renewed
2001-01-11	KB	Patent renewed
2004-11-10	KB	Patent renewed
2009-02-11	KB	Patent renewed
2010-04-14	KB	Patent renewed
2011-06-30	EXP	Patent expired

Publication	Publication Date	Title
CA2026280C (fr)	2003-04-15	Adn marque a la biotine par reaction en chaine avec la polymerase et sa detection
US20240344097A1 (en)	2024-10-17	Amplicon rescue multiplex polymerase chain reaction for amplification of multiple targets
EP0457824B1 (fr)	1999-06-23	Detection d'une sequence d'acides nucleiques ou d'un changement dans celle-ci
EP0359789B1 (fr)	1993-08-04	Amplification et detection de sequences d'acides nucleiques
US5989817A (en)	1999-11-23	Target nucleic acid and capture method
US7951541B2 (en)	2011-05-31	Assay kit for use in method of detecting a target nucleic acid
EP0408918B1 (fr)	1993-11-18	Méthode de détection d'acide nucléique
AU5359690A (en)	1990-10-22	Polymerase chain reaction products incorporating reporter moieties and affinity seperation
AU723602B2 (en)	2000-08-31	Biotin-labelled DNA by polymerase chain reaction and detection thereof
JP3396218B2 (ja)	2003-04-14	核酸検出方法
JPH03123500A (ja)	1991-05-27	核酸の分別方法
JPH07284391A (ja)	1995-10-31	ヒトヘルペスウイルス検出用オリゴヌクレオチドおよびその用途
JPH05236998A (ja)	1993-09-17	核酸検出方法
CA2012984A1 (fr)	1990-09-27	Procede pour la detection rapide de l'acide nucleique par incorporation d'un groupe marqueur dans l'acide nucleique detecte par amplification de la cible, et ensuite par capture par affinite
JPH1014572A (ja)	1998-01-20	プローブライブラリーの製造方法、該製造方法により得られたプローブライブラリー、該プローブライブラリーから他のｄｎａまたはｒｎａとハイブリッドするプローブを精製する方法、及び該方法により精製したプローブ